Review
doi: 10.1016/S1470-2045(09)70287-6.
The metabolic syndrome in cancer survivors
Affiliations
- PMID: 20152771
- DOI: 10.1016/S1470-2045(09)70287-6
Item in Clipboard
Review
The metabolic syndrome in cancer survivors
Lancet Oncol.
2010 Feb.
Abstract
The metabolic syndrome, as a cluster of cardiovascular risk factors, may represent an important connection between cancer treatment and its common late effect of cardiovascular disease. Insight into the aetiology of the metabolic syndrome after cancer treatment might help to identify and treat cancer survivors with increased cardiovascular risk. In this review, we summarise current knowledge on the prevalence and pathophysiology of the metabolic syndrome in cancer survivors, and discuss current intervention strategies with an emphasis on new developments.
Copyright 2010 Elsevier Ltd. All rights reserved.
Comment in
-
On treating metabolic syndrome: emphasise lifestyle change.Lancet Oncol. 2010 May;11(5):415. doi: 10.1016/S1470-2045(10)70055-3. Lancet Oncol. 2010. PMID: 20434715 No abstract available.
Similar articles
-
Metabolic syndrome in pediatric cancer survivors: a mechanistic review.Pediatr Blood Cancer. 2013 Dec;60(12):1922-8. doi: 10.1002/pbc.24703. Epub 2013 Aug 1. Pediatr Blood Cancer. 2013. PMID: 23913590 Review.
-
The metabolic syndrome in adult survivors of childhood cancer, a review.J Pediatr Hematol Oncol. 2010 Apr;32(3):171-9. doi: 10.1097/MPH.0b013e3181d419c3. J Pediatr Hematol Oncol. 2010. PMID: 20186100 Review.
-
The metabolic syndrome and type 2 diabetes.Minerva Endocrinol. 2005 Sep;30(3):139-59. Minerva Endocrinol. 2005. PMID: 16208305 Review.
-
[Cancer and cardiovascular disease].Clin Investig Arterioscler. 2015 Sep-Oct;27(5):221-5. doi: 10.1016/j.arteri.2015.02.002. Epub 2015 Mar 12. Clin Investig Arterioscler. 2015. PMID: 25772547 Review. Spanish.
-
Cardiovascular risk: prevention and treatment of the metabolic syndrome.Diabetes Res Clin Pract. 2005 Jun;68 Suppl 2:S28-35. doi: 10.1016/j.diabres.2005.03.018. Epub 2005 Apr 15. Diabetes Res Clin Pract. 2005. PMID: 15953504 Review.
Cited by
-
Metabolic syndrome and the risk of colorectal cancer: a systematic review and meta-analysis.Int J Colorectal Dis. 2021 Oct;36(10):2215-2225. doi: 10.1007/s00384-021-03974-y. Epub 2021 Jul 31. Int J Colorectal Dis. 2021. PMID: 34331119
-
Competing risks of cancer mortality and cardiovascular events in individuals with multimorbidity.J Comorb. 2014 Aug 18;4:29-36. doi: 10.15256/joc.2014.4.41. eCollection 2014. J Comorb. 2014. PMID: 29090151 Free PMC article.
-
Risk Factors and Prevention of Cancer and CVDs: A Chicken and Egg Situation.J Clin Med. 2025 Apr 29;14(9):3083. doi: 10.3390/jcm14093083. J Clin Med. 2025. PMID: 40364115 Free PMC article. Review.
-
Assessment of the Predictive Role of Serum Lipid Profiles in Breast Cancer Patients Receiving Neoadjuvant Chemotherapy.J Breast Cancer. 2020 Jun;23(3):246-258. doi: 10.4048/jbc.2020.23.e32. J Breast Cancer. 2020. PMID: 32595987 Free PMC article.
-
Biomarkers Predictive of Metabolic Syndrome and Cardiovascular Disease in Childhood Cancer Survivors.J Pers Med. 2022 May 27;12(6):880. doi: 10.3390/jpm12060880. J Pers Med. 2022. PMID: 35743665 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
